Clinical Trial Update: Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cemiplimab plus ziv-aflibercept for metastatic uveal melanoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• Cemiplimab (cemiplimab)
• Zaltrap (ramucirumab)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Metastatic Uveal Melanoma | Phase 2 | Status: RECRUITING